Treating Hyperkalemia in Patients with Heart Failure: Making the Right Choices

Please claim your continuing education credit on the Medscape site!

Treating Hyperkalemia in Patients with Heart Failure: Making the Right Choices

Take a closer look at optimizing RAASi therapy by exploring the evidence and options with potassium binders.

Treating Hyperkalemia in Patients with Heart Failure: Making the Right Choices: Renin-angiotensin-aldosterone system inhibitor (RAASi) therapy decreases cardiovascular morbidity and mortality in patients with heart failure (HF). Evidence-based HF guidelines support the titration of RAASi to achieve target doses to optimize treatment benefits.

Faculty: Mikhail Kosiborod, MD
Nancy M. Albert, PhD, CCNS, CCRN, NE-BC
Akshay S. Desai, MD, MPH
Orly Vardeny, PharmD, MS

Access the ondemand course here!

Claim your credit on the Medscape site!

Summary


Cost:	FREE


Credit:	No Credit Offered

Create Account

Recommended

Advancing The Prevention and Treatment of Heart Failure

Please claim your continuing education credits on the Medscape site!

No Credit

FREE

How Do We Practically Do This?” Expert Guidance and Interactive Practice on SGLT2i Integration Across the Spectrum of Heart Failure

Please claim your continuing education credits at the CCO website!

No Credit

FREE

CardioBites: Congestion

No Credit

FREE

Heart Failure Seminar: Updates in Advance Heart Failure, LVAD Is In Place, Now What? Current Thoughts on Antithrombetic Therapy

Multiple Credits

$0.00 - $59.00

Heart Failure Beat Podcast: Equity in Heart Transplant - The Conversation Continues - Episode 19

No Credit

FREE